skip navigation and go directly to content

NIH
DHHS

Consensus Development Program logo and link to CDP home pagestylized image of panel at Natcher conference center
    

   CDP Home    Previous Conferences   CME   About the Consensus Program

 

Welcome to the CME testing site for the NIH State-of-the-Scicence conference on Symptom Management in Cancer: Pain, Depression and Fatigue

The National Institutes of Health/Foundation for Advanced Education in the Sciences is accredited by the Accreditation Councilfor Continuing Medical Education to provide continuing medical education for physicians.

The National Institutes of Health/Foundation for Advanced Education in the Sciences designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.

The authors of the conference statement (conference panelists) have signed disclosure forms indicating that they have no conflicts of interest (commercial, financial or scientific) with respect to the topic or the conference questions under consideration. Individuals with conflicts are eliminated from consideration as panelists in the Consensus Development Program process. Click here to view off-label or investigational drugs or devices that were discussed in the statement.

These CME materials were approved on October 15, 2003 and will expire on October 15, 2006.
We need to have the information below in order to process your CME credit, required fields are in RED. Read the statement (click here to retrieve statement) The consensus statement contains the correct answers to all of the questions listed below. Answer ALL of the test questions. If you are not sure of an answer after reading the statement, just click on the help link next to each question and reread the appropriate section.

If you achieve a score of 70% or more, you will be able to print your CME certificate from this online site, but if you don't manage to achieve a passing score, you are welcome to try again.
If you have any trouble printing out your certificate, please call 301-496-1144 or email: maskes@od.nih.gov.
Good Luck!

First Name

Middle Initial

Last Name

Degree



Street Address

City

State

Zip

Country

Phone

FAX

E-mail

Month/Day of Birth
(mm/dd)

M.D or non-M.D.
participant?

System Requirements----Sponsors----Privacy Statement----Contact Information

1. Of the 1.3 million people diagnosed with cancer in 2002, what percentage will survive at least five years after diagnosis? help

2. Estimates of the frequency of pain, depression and fatigue in cancer patients are well established.help

3. The most common clinical assessment for pain, depression and fatigue is: help

4. Which of the following patient characteristics should be considered as possibly affecting presentation and treatment of symptoms? help

5. Asking patients about pain severity and impairment due to pain may be feasible and useful for recommending treatments for pain. help

6. Which of the following are types of instruments are most commonly used for assessing depression? help

7. The common-sense WHO three-step analgesic ladder is: help

8. Randomized controlled trials of antidepressants have shown benefit when used at an adequate dose and duration. help

9. Convincing evidence for effective treatment of fatigue exists for which of the following: help

10. Provider barriers to effective management include all but which of the following: help

11. Which of the following are barriers to effective pain management that affect patients and families: help

12. System barrier to effective pain management include all but the following: help

13. Lack of recognition of depression and inadequate resources for treatment is a serious impediment to management. help

14. Serious barriers to management of fatigue include all but which of the following: help

15. Strategies for improving symptom management involve: help

16. Strategies for alleviating system barriers include: help

17. All patients should have access to adequate and timely pain control. help

18. Education and awareness of the need for adequate pain management: help

19. Triplicate prescriptions have been shown to efficaciously reduce fraud. help

Your response to the following questions, while greatly appreciated, is optional and will have no effecton the test score
Rating of Objectives and Program

Please rate the attainment of objectives.
Upon completion of this CME activity how well did you feel you can describe the issues related to the following conference questions:

a) What is the occurrence of pain, depression, and fatigue, alone and in combination, in people with cancer?

b) What are the methods used for clinical assessment of these symptoms throughout the course of cancer, and what is the evidence for their reliability and validity in cancer patients?

c)What are the treatments for cancer-related pain, depression, and fatigue, and what is the evidence for their effectiveness?

d) What are the impediments to effective symptom management in people diagnosed with cancer, and what are optimal strategies to overcome these impediments?

The overall quality of the instructional process was an asset to this CME program

To what extent will participation in this CME activity enhance your professional effectiveness?

Did you perceive any commercial bias;

If yes, please explain:

What comments or suggstions do you have for the faculty (statement authors)?

What will you do differently as a result of this educational activity?

Are there new topics you would like covered in this activity or in a related activity?

Do you have additional comments to enhance the utility or impact of the activity?

Office of Medical Applications of Research
6100 Executive Blvd. Room 2B03
Bethesda, MD 20892
Phone: 301-496-1144
Fax: 301-402-0420


skip navigation and go directly to content

 skip navigation

skip navigation and go directly to content[ Q&A About NIH | Visitor Information | Search | Contact NIH | Contact Consensus Program]
[ Privacy Notice | Disclaimer | Accessibility ]


NIH 

National Institutes of Health
9000 Rockville Pike
Bethesda, Maryland 20892

   DHHS 

Department of Health
and Human Services

 

 FirstGov 

National Guideline Clearinghouse